Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 18, 2025 09:54 ET | Source: Research and Markets

Epilepsy Therapeutics Market Trends, Competitive Strategies and Forecasts Report 2025-2033 | Personalized Medicine Paves New Pathways in Treatment, Third-Generation Therapeutics Lead Growth

Dublin, July 18, 2025 (GLOBE NEWSWIRE) -- The "Epilepsy Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
February 24, 2025 09:30 ET | Source: Synergia Medical

SYNERGIA MEDICAL ANNOUNCES STRONG RESULTS FOR NAO.VNS™ FIRST-IN-HUMAN STUDY

Primary safety endpoint met - No serious adverse events reported over 3-monthsRobust device performance - No device failure reported over 3-months Synergia Medical announces that its NAO.VNS™...
February 18, 2025 10:38 ET | Source: Research and Markets

Epilepsy Drugs Market Research 2025-2033: Marketed Medications/Drugs, Emerging Drugs, Regulations and Reimbursement Policies, Key Players Analysis

Dublin, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The "Epilepsy Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's...
January 13, 2025 03:00 ET | Source: Synergia Medical

SYNERGIA MEDICAL ANNOUNCES: FIVE PATIENTS NOW IMPLANTED WITH NAO.VNS™ LEADERSHIP CHANGE: CHARLES NOLET TO SUCCEED ATTILA BORBATH AS CEO

Brussels, January 13, 2025. Synergia Medical SA, a leader in developing optoelectronic medical devices, is pleased to announce the successful implantation of its groundbreaking NAO.VNSTM system in...
September 23, 2024 02:08 ET | Source: Synergia Medical

Synergia Medical Successfully Implants First Patients With NAO.VNS™

Brussels, 23 September 2024 – Synergia Medical, a leader in the development of optoelectronic medical devices, is pleased to announce the successful implantation of its groundbreaking NAO.VNS system...